---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-060902"
form_type: "8-K"
ticker: "ACXP"
cik: "0001736243"
company_name: "Acurx Pharmaceuticals, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:36:02.914530+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Acurx Pharma raises $2.67M via warrant exercise; issues new warrants for ~8.89M shares

## Summary
- Entered warrant inducement agreement; holder exercised ~4.45M existing warrants at reduced $0.60/share, gross proceeds $2.67M.
- Net proceeds ~$2.3M after fees; used for working capital and general corporate purposes.
- Issued new G-1 and G-2 warrants to purchase up to 8,890,870 shares at $0.425/share; G-1 exercisable immediately, G-2 upon shareholder approval.
- H.C. Wainwright gets 7% fee and warrants to purchase 266,726 shares at $0.75/share.
- Expected close June 20, 2025; 45-day stock issuance restriction and 90-day variable rate transaction restriction.

## SEC filing metadata
- accession: 0001104659-25-060902
- form_type: 8-K
- ticker: ACXP
- cik: 0001736243
- company_name: Acurx Pharmaceuticals, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/0001104659-25-060902-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925060902/tm2518285d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-060902
- JSON: https://secwatch.observer/filing/0001104659-25-060902.json
- Plain text: https://secwatch.observer/filing/0001104659-25-060902.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.